Genmab AS Sustainability Reports
Genmab A/S is a biotechnology company specializing in the development of differentiated antibody therapeutics for the treatment of cancer.
Sector: Health Care
Country: Denmark
Exchange: Copenhagen Stock Exchange
ISIN: DK0010272202
23 reports from 2007 to 2025
Company Profile
Genmab AS
Genmab A/S is a biotechnology company specializing in the development of differentiated antibody therapeutics for the treatment of cancer.
Reports